GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 90 filers reported holding GENERATION BIO CO in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $128,000 | -7.9% | 19,400 | 0.0% | 0.00% | – |
Q1 2022 | $139,000 | +9.4% | 19,400 | +10.2% | 0.00% | – |
Q4 2021 | $127,000 | -69.4% | 17,600 | +2.9% | 0.00% | -100.0% |
Q3 2021 | $415,000 | -8.6% | 17,100 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $454,000 | -0.2% | 17,100 | 0.0% | 0.00% | -50.0% |
Q1 2021 | $455,000 | -19.2% | 17,100 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $563,000 | – | 17,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Life Science Advisors, LLC | 8,278,876 | $43,961,000 | 4.85% |
GREAT POINT PARTNERS LLC | 825,077 | $4,381,000 | 1.06% |
HighVista Strategies LLC | 248,994 | $1,322,000 | 0.76% |
Artal Group S.A. | 2,814,191 | $14,943,000 | 0.64% |
PFM Health Sciences, LP | 3,013,712 | $16,003,000 | 0.58% |
HARVARD MANAGEMENT CO INC | 510,354 | $2,710,000 | 0.34% |
Yiheng Capital Management, L.P. | 997,857 | $5,299,000 | 0.33% |
Bellevue Group AG | 3,627,280 | $19,261,000 | 0.28% |
BVF INC/IL | 361,824 | $1,921,000 | 0.08% |
FARALLON CAPITAL MANAGEMENT LLC | 2,500,000 | $13,275,000 | 0.07% |